izpis_h1_title_alt

Influence of excipient composition on survival of vaginal lactobacilli in electrospun nanofibers
ID Stojanov, Spase (Author), ID Kristl, Julijana (Author), ID Zupančič, Špela (Author), ID Berlec, Aleš (Author)

.pdfPDF - Presentation file, Download (4,67 MB)
MD5: 8ABEB7064345AC5A8852313A6E0E74E6
URLURL - Source URL, Visit https://www.mdpi.com/1999-4923/14/6/1155 This link opens in a new window

Abstract
The lack of appropriate delivery systems hinders the use of probiotics in the treatment of vaginal infections. Therefore, the development of a new delivery system for the local administration of vaginal probiotics is necessary. In this study, we selected three vaginal lactobacilli, i.e., Lactobacillus crispatus, Lactobacillus gasseri, and Lactobacillus jensenii, and incorporated them into nanofibers using electrospinning. Polyethylene oxide (PEO) was used as a carrier polymer to produce nanofibers. It was supplemented with alginate and sucrose selected from a group of carbohydrates for their growth-promoting effect on lactobacilli. The interaction between excipients and lactobacilli was evaluated thermally and spectroscopically. Bacterial survival in polymer solutions and in nanofibers immediately after electrospinning and after storage varied among species and was dependent on the formulation. Sucrose improved the survival in polymer solutions and preserved the viability of L. crispatus and L. jensenii immediately after electrospinning, and L. gasseri and L. jensenii during storage. Blending PEO with alginate did not improve species viability. However, the three lactobacilli in the nanofibers retained some viability after 56 days, indicating that composite multifunctional nanofibers can maintain the viability of vaginal lactobacilli and can be used as a potential solid delivery system for vaginal administration of probiotics.

Language:English
Keywords:vaginal probiotics, electrospinning, nanofibers, viability, lyoprotectants, carbohydrates, delivery system
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:17 str.
Numbering:Vol. 14, iss. 6, art. 1155
PID:20.500.12556/RUL-137799-d26a2efb-4bfa-46a4-ca7f-b684910b28cc This link opens in a new window
UDC:66.017-022.513.2:615.015.14
ISSN on article:1999-4923
DOI:10.3390/pharmaceutics14061155 This link opens in a new window
COBISS.SI-ID:110284547 This link opens in a new window
Publication date in RUL:01.07.2022
Views:741
Downloads:97
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Pharmaceutics
Shortened title:Pharmaceutics
Publisher:MDPI
ISSN:1999-4923
COBISS.SI-ID:517949977 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:nanovlakna, dostavni sistemi

Projects

Funder:ARRS - Slovenian Research Agency
Project number:N3-0184
Name:Majhni proteinski blokatorji osi IL-23/IL-17, izločeni iz probiotičnih bakterij, kot zaviralci vnetja prebavil

Funder:ARRS - Slovenian Research Agency
Project number:P1-0189
Name:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Funder:ARRS - Slovenian Research Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Funder:Other - Other funder or multiple funders
Funding programme:Public Scholarship, Development, Disability and Maintenance Fund of the Republic of Slovenia, Ad Futura

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back